Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 142
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Article in English | MEDLINE | ID: mdl-39239956

ABSTRACT

BACKGROUND: Rosacea is a chronic, relapsing inflammatory dermatosis predominantly affecting the central face and can result in significant psychosocial impacts. Isotretinoin has been studied for rosacea due to its anti-inflammatory and sebum reduction properties, but its use remains limited likely due to its off-label use and potential adverse events. OBJECTIVE: This systematic review and meta-analysis investigated the efficacy and safety of low-dose isotretinoin (LDI; ≤0.5 mg/kg/day) for the four main types of rosacea: erythematotelangiectatic, papulopustular, phymatous and ocular rosacea. METHODS: Randomized and non-randomized studies evaluating LDI for rosacea were included. Incomplete studies, non-English studies and case reports were excluded. Study quality was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation scale. RESULTS: Of 435 studies, and 16 studies involving 1445 patients were included. LDI decreased lesion count (p = 0.03) and erythema (p = 0.01) with large effect [standardized mean difference (SMD) > 0.8]. Compared to topical retinoids and topical antimicrobials, isotretinoin had larger reductions in lesion count (p = 0.03) with moderate effect (SMD > 0.5). Mean lesion count and erythema remained reduced by 70% and 47%, respectively, at 16 weeks after LDI cessation. Relapse rate was 35% at 5.5 months post-isotretinoin, and three patients (0.4%) experienced worsening of rosacea. Three patients (0.4%) experienced serious adverse events. CONCLUSIONS: Study design heterogeneity limited more comprehensive comparisons. Overall, low-dose isotretinoin may serve as an effective treatment for rosacea with good tolerability and safety.

2.
J Drugs Dermatol ; 23(4): 262-267, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38564403

ABSTRACT

BACKGROUND: Full thickness defects of the ala, soft triangle, and nasal tip involving the nasal lining have traditionally been repaired with the three-stage folded paramedian forehead flap (FPFF), with a cartilage graft for support. For similar defects, the authors utilize the two-stage FPFF without cartilaginous support which provides reproducible functional and aesthetic results.  Objective: To describe the authors’ experience with the two-stage FPFF, including outcomes, complications, and design modifications to enhance functional and aesthetic success.  Methods: An IRB-approved retrospective database review of FPFF was performed at two sites. Using postoperative photographs, outcomes were assessed by blinded non-investigator dermatologist raters using a modified observer scar assessment scale. RESULTS: Thirty-five patients were reconstructed using the two-stage FPFF without cartilage grafts. Subjective assessment of scar vascularity, pigment, relief, and thickness by 3 independent reviewers yielded an overall cosmesis score of 8.4±1.9 (out of 40). CONCLUSION: The two-stage FPFF without cartilage grafts is a reliable, cosmetically elegant repair that can provide optimal functional and aesthetic results for complex unilateral distal nose defects.J Drugs Dermatol. 2024;23(4): doi:10.36849/JDD.7358.


Subject(s)
Nose Neoplasms , Rhinoplasty , Humans , Rhinoplasty/methods , Surgical Flaps , Retrospective Studies , Forehead/surgery , Cicatrix/pathology , Nose/surgery , Cartilage/transplantation , Nose Neoplasms/surgery , Nose Neoplasms/pathology
3.
Dermatol Surg ; 49(5): 451-455, 2023 05 01.
Article in English | MEDLINE | ID: mdl-36989088

ABSTRACT

BACKGROUND: Mohs micrographic surgery (MMS) for cutaneous melanoma has demonstrated higher cure rates, lower local recurrence rates, and improved survival compared with wide local excision (WLE). However, factors affecting referrals by general dermatologists for MMS of head and neck melanoma (HNM) are unknown. OBJECTIVE: To elucidate referral factors and treatment perspectives of general dermatologists regarding MMS for melanoma in situ (MIS)/lentigo maligna (LM) and early-stage melanoma on the head and neck. MATERIALS AND METHODS: A cross-sectional analysis was performed using survey responses of general dermatologists with membership in the American Academy of Dermatology . RESULTS: A total of 231 and 132 of the 402 responding general dermatologists routinely referred melanoma in situ MIS/LM and early invasive melanoma for MMS, respectively. Lack of local access to a Mohs surgeon was the most common deterring reason for MIS/LM referral to MMS, whereas the preference for WLE was the most common deterring reason for early invasive melanoma. CONCLUSION: Lack of local access to a Mohs surgeon treating HNM with MMS is the primary barrier in referrals to Mohs surgeons for MIS and LM. Among general dermatologists, WLE is preferred for early invasive HNM.


Subject(s)
Hutchinson's Melanotic Freckle , Melanoma , Skin Neoplasms , Humans , Melanoma/diagnosis , Melanoma/surgery , Skin Neoplasms/surgery , Cross-Sectional Studies , Mohs Surgery , Dermatologists , Hutchinson's Melanotic Freckle/surgery , Neoplasm Recurrence, Local/epidemiology , Neoplasm Recurrence, Local/surgery , Retrospective Studies , Melanoma, Cutaneous Malignant
4.
J Am Acad Dermatol ; 85(1): 18-27, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33684494

ABSTRACT

Subepidermal (subepithelial) autoimmune blistering dermatoses are a group of rare skin disorders characterized by the disruption of the dermal-epidermal junction through the action of autoantibodies. The fourth article in this continuing medical education series presents the current validated disease activity scoring systems, serologic parameters, treatments, and clinical trials for bullous pemphigoid, mucous membrane pemphigoid, epidermolysis bullosa acquisita, bullous systemic lupus erythematosus, anti-p200 pemphigoid, linear IgA bullous dermatosis, and dermatitis herpetiformis.


Subject(s)
Autoantibodies/blood , Autoimmune Diseases/drug therapy , Immunologic Factors/administration & dosage , Photochemotherapy/methods , Skin Diseases, Vesiculobullous/drug therapy , Administration, Cutaneous , Administration, Oral , Autoantibodies/immunology , Autoimmune Diseases/blood , Autoimmune Diseases/diagnosis , Autoimmune Diseases/immunology , Biomarkers/blood , Clinical Trials as Topic , Cytokines/blood , Cytokines/immunology , Dermis/immunology , Dermis/pathology , Drug Therapy, Combination/methods , Glucocorticoids/administration & dosage , Humans , Severity of Illness Index , Skin Diseases, Vesiculobullous/blood , Skin Diseases, Vesiculobullous/diagnosis , Skin Diseases, Vesiculobullous/immunology , Treatment Outcome
5.
J Am Acad Dermatol ; 85(1): 1-14, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33684496

ABSTRACT

Subepithelial autoimmune blistering dermatoses are a group of rare skin disorders that are characterized by the disruption of the dermal-epidermal junction through the action of autoantibodies. The third article in this continuing medical education series explores the background, epidemiology, clinical features, and diagnostic criteria of each of the major subepithelial autoimmune blistering dermatoses, including bullous pemphigoid, pemphigoid gestationis, lichen planus pemphigoides, mucous membrane pemphigoid, linear IgA bullous dermatosis, and dermatitis herpetiformis.


Subject(s)
Autoimmune Diseases/diagnosis , Lichen Planus/diagnosis , Pemphigoid Gestationis/diagnosis , Skin Diseases, Vesiculobullous/diagnosis , Autoimmune Diseases/epidemiology , Autoimmune Diseases/immunology , Autoimmune Diseases/pathology , Dermis/immunology , Dermis/pathology , Female , Humans , Lichen Planus/epidemiology , Lichen Planus/immunology , Lichen Planus/pathology , Pemphigoid Gestationis/epidemiology , Pemphigoid Gestationis/immunology , Pemphigoid Gestationis/pathology , Pregnancy , Skin Diseases, Vesiculobullous/epidemiology , Skin Diseases, Vesiculobullous/immunology , Skin Diseases, Vesiculobullous/pathology
6.
J Am Acad Dermatol ; 84(6): 1507-1519, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33684498

ABSTRACT

Intraepithelial autoimmune blistering dermatoses are a rare group of skin disorders characterized by the intraepithelial disruption of intercellular connections through the action of autoantibodies. The first article in this continuing medical education series explores the background, epidemiology, clinical features, and diagnostic criteria of each of the major intraepithelial autoimmune blistering dermatoses, including pemphigus foliaceus, pemphigus erythematosus, pemphigus herpetiformis, fogo selvagem, pemphigus vulgaris, pemphigus vegetans, drug-induced pemphigus, IgA pemphigus, IgG/IgA pemphigus, and paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome.


Subject(s)
Autoimmune Diseases/diagnosis , Skin Diseases, Vesiculobullous/diagnosis , Skin/pathology , Autoimmune Diseases/epidemiology , Autoimmune Diseases/immunology , Autoimmune Diseases/pathology , Diagnosis, Differential , Humans , Skin/immunology , Skin Diseases, Vesiculobullous/epidemiology , Skin Diseases, Vesiculobullous/immunology , Skin Diseases, Vesiculobullous/pathology
7.
J Am Acad Dermatol ; 84(6): 1523-1537, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33684497

ABSTRACT

Intraepithelial autoimmune blistering dermatoses are a rare group of skin disorders characterized by disruptions of inter-keratinocyte connections within the epidermis through the action of autoantibodies. The second article in this continuing medical education series presents validated disease activity scoring systems, serologic parameters of disease, treatments, and clinical trials for pemphigus and its subtypes.


Subject(s)
Autoantibodies/blood , Autoimmune Diseases/therapy , Immunologic Factors/therapeutic use , Plasma Exchange , Skin Diseases, Vesiculobullous/therapy , Administration, Cutaneous , Administration, Oral , Autoantibodies/immunology , Autoimmune Diseases/blood , Autoimmune Diseases/diagnosis , Autoimmune Diseases/immunology , Drug Therapy, Combination/methods , Humans , Injections, Intralesional , Severity of Illness Index , Skin/immunology , Skin/pathology , Skin Diseases, Vesiculobullous/blood , Skin Diseases, Vesiculobullous/diagnosis , Skin Diseases, Vesiculobullous/immunology , Treatment Outcome
8.
Pediatr Dermatol ; 38(3): 580-584, 2021 May.
Article in English | MEDLINE | ID: mdl-33644931

ABSTRACT

BACKGROUND/OBJECTIVE: There are few studies examining pediatric scarring alopecia. The objective of this study is to characterize the clinicopathologic findings, comorbidities, and treatment outcomes of pediatric patients with scarring alopecia. METHODS: Retrospective review of patients under age 18 diagnosed with scarring alopecia at Mayo Clinic from 01/01/1992 through 02/05/2019. RESULTS: 27 patients met inclusion criteria with a mean age of 11.2 years and a racial breakdown of 85.2% (23) White, 11.1% (3) Black, and 3.7% (1) Multiracial. Clinical scarring was noted in most (23, 85.2%). Biopsy confirmed the diagnosis in most (24, 88.9%). The most common diagnoses were folliculitis decalvans (6, 22.2%), lichen planopilaris (6, 22.2%), aplasia cutis congenita (4, 14.8%), tinea capitis (4, 14.8%), and morphea (3, 11.1%). Comorbid depression (6, 22.2%) and anxiety (6, 22.2%) were prevalent. Of the patients who received follow-up, most who pursued treatment achieved stabilization (55.5%) or slowing of progression (27.8%), with 44.4% of those treated experiencing regrowth. Mean time to stabilization in the treated population was 19.6 months. Two patients did not pursue treatment, but received follow-up and these untreated patients did not experience hair regrowth. CONCLUSIONS: Most patients presented with clinically evident primary scarring alopecia. Biopsy may confirm the diagnosis. Active treatment should be pursued, and successful treatment often requires combination therapies. Time to stabilization often takes years. Screening for depression and anxiety should be pursued.


Subject(s)
Cicatrix , Lichen Planus , Adolescent , Alopecia/diagnosis , Alopecia/epidemiology , Child , Cicatrix/epidemiology , Cicatrix/pathology , Hair/pathology , Humans , Retrospective Studies
9.
Dermatol Online J ; 27(1)2021 01 15.
Article in English | MEDLINE | ID: mdl-33560798

ABSTRACT

Apocrine hidrocystoma is a benign, cystic proliferation of the apocrine sweat gland that may present commonly on sun-exposed areas of the head and neck. However, given its location and features, apocrine hidrocystomas may often be confused with malignant tumors such as basal cell carcinomas or primary cutaneous mucinous carcinomas. Herein, we present an unusual case of an apocrine hidrocystoma presenting in the postauricular region and highlight the importance of histopathological examination of cystic tumors on the periauricular area.


Subject(s)
Head and Neck Neoplasms/pathology , Hidrocystoma/pathology , Sweat Gland Neoplasms/pathology , Adenocarcinoma, Mucinous/diagnosis , Carcinoma, Basal Cell/diagnosis , Diagnosis, Differential , Epidermal Cyst/diagnosis , Female , Head and Neck Neoplasms/therapy , Hidrocystoma/therapy , Humans , Middle Aged , Skin Neoplasms/diagnosis , Sweat Gland Neoplasms/therapy
10.
Dermatol Online J ; 27(12)2021 Dec 15.
Article in English | MEDLINE | ID: mdl-35499448

ABSTRACT

BACKGROUND: Reconstruction of surgical defects on the dorsal finger can be challenging because of a lack of adjacent tissue reservoirs, poor laxity, and often thin, atrophic skin surrounding the defect. OBJECTIVE: To present reconstructive options for cutaneous dorsal finger defects. METHODS: We describe our five preferred approaches to reconstructing cutaneous dorsal finger defects based on the amount of available underlying tissue and location of the defect on the finger. RESULTS: In the authors' opinion, for smaller defects between and including the metacarpophalangeal joint extending to the proximal interphalangeal joint, a transposition flap or unilateral advancement flap is preferable. For proximal finger defects that are wider, a unilateral rotation flap is appropriate. A Burow full-thickness skin graft can be used for any proximal defect with underlying soft tissue present. For defects with underlying bone or tendon present, a reverse cross-finger interpolation flap can be utilized. CONCLUSIONS: The unilateral advancement flap, unilateral rotation flap, transposition flap, full-thickness skin grafts, or the reverse cross-finger interpolation flap can be used to reconstruct the majority of cutaneous dorsal finger defects.


Subject(s)
Finger Injuries , Finger Injuries/surgery , Fingers/surgery , Humans , Skin/injuries , Skin Transplantation , Surgical Flaps/surgery
11.
J Am Acad Dermatol ; 83(2): 493-500, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32289390

ABSTRACT

BACKGROUND: Basal cell carcinomas (BCCs) with high-risk features are preferably treated by Mohs micrographic surgery. Studies have shown clinicopathologic characteristics that may predict more stages required for clearance. However, few studies have correlated such factors with the number of millimeters removed per stage. OBJECTIVE: To determine margins necessary for BCC clearance according to tumor features, especially for tumors less than 6 mm, and to suggest initial margins for Mohs micrographic surgery and margins for wide local excision. METHODS: Retrospective analysis of 295 consecutive Mohs micrographic surgeries for primary BCCs. Variables analyzed included patient age, sex, immunostatus, lesion size, location, histologic subtype, borders, stage number, and millimeters excised per stage. RESULTS: BCCs less than 6 mm had a clearance rate of 96% with 3-mm margins. In adjusted multivariable analysis, superficial, micronodular, infiltrative, and morpheaform subtypes were associated with larger margins, whereas clinically well-defined tumors were associated with smaller margins. LIMITATIONS: Because of the limited sample of certain subtypes, a 3-mm margin is better suited for nodular tumors. CONCLUSION: These data help guide initial Mohs micrographic surgery and wide local excision margins required for tumor clearance according to tumor features. Nodular BCCs less than 6 mm may be cleared with 3-mm margins instead of the current 4-mm margin recommendation.


Subject(s)
Carcinoma, Basal Cell/surgery , Margins of Excision , Mohs Surgery/standards , Practice Guidelines as Topic , Skin Neoplasms/surgery , Adult , Aged , Aged, 80 and over , Carcinoma, Basal Cell/pathology , Female , Humans , Male , Middle Aged , Mohs Surgery/statistics & numerical data , Neoplasm Staging , Retrospective Studies , Skin/pathology , Skin Neoplasms/pathology , Treatment Outcome
12.
J Am Acad Dermatol ; 82(3): 634-641, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31344376

ABSTRACT

BACKGROUND: Focal or total skin radiation therapy can be used to treat mild to refractory cutaneous T-cell lymphoma. OBJECTIVE: To report the broad therapeutic benefit of radiation therapy for cutaneous T-cell lymphoma. METHODS: Retrospective, single-institution review of outcomes for skin-directed radiation therapy. RESULTS: Skin-directed radiation therapy showed a 99% response rate and 80% complete response rate after treatment regardless of involvement, severity, histopathologic subtype, dose, or fractionation. The overall in-field recurrence rate was 15%, and median time to recurrence was 296 days (range, 1-1884 days). Focal and hypofractionated regimens were similarly associated with disease response and rare toxicity. Short-term rates of secondary skin cancer after treatment were comparable to expected incidence in a patient population without radiation. LIMITATIONS: Large total number of treatments courses compared with overall number of patients. Heterogenous mix of treatment regimens (no standardization of dose or fraction number). CONCLUSIONS: Radiation therapy is a well-tolerated treatment option for properly selected patients with cutaneous T-cell lymphoma.


Subject(s)
Lymphoma, T-Cell, Cutaneous/radiotherapy , Skin Neoplasms/radiotherapy , Aged , Female , Humans , Male , Radiotherapy/methods , Retrospective Studies , Skin , Treatment Outcome
13.
J Am Acad Dermatol ; 82(6): 1346-1359, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31560977

ABSTRACT

BACKGROUND: Pyoderma gangrenosum (PG) is a devastating neutrophilic dermatosis that may be associated with trauma or systemic diseases. The associations, characteristics, and temporal relationship of PG with hematologic malignancies are not well understood. OBJECTIVE: We performed a systematic review of PG associated with hematologic malignancies using data from case reports, case series, and retrospective studies. METHODS: We searched MEDLINE, EMBASE, Scopus, and Web of Science from each database's inception to December 12, 2018. Two reviewers independently selected studies and extracted data. RESULTS: Two hundred seventy-nine publications met the inclusion criteria (340 cases). Myelodysplastic syndrome (MDS) was the most commonly reported hematologic malignancy associated with PG, followed by monoclonal gammopathy of undetermined significance and acute myeloid leukemia. The mean age of patients was 56.5 years, with males being more common. There was a predominance of the ulcerative PG subtype and multifocal distributions across all hematologic malignancies. The majority of MDS cases preceded PG, which was reversed for MGUS. LIMITATIONS: The data were limited by reporting bias because PG subtypes rely on the rendered diagnosis reported. In addition, the classification for hematologic malignancies has evolved since 1978. CONCLUSION: Patients with PG should be evaluated for hematologic malignancies, with MDS being the most common.


Subject(s)
Hematologic Neoplasms/complications , Monoclonal Gammopathy of Undetermined Significance/complications , Myelodysplastic Syndromes/complications , Pyoderma Gangrenosum/complications , Hematologic Neoplasms/pathology , Humans , Leukemia, Myeloid, Acute/complications , Myelodysplastic Syndromes/pathology , Pyoderma Gangrenosum/drug therapy
18.
Dermatol Surg ; 45(3): 340-357, 2019 03.
Article in English | MEDLINE | ID: mdl-30640780

ABSTRACT

BACKGROUND: The facial nerve and its branches are at risk of injury during dermatologic surgery. Few publications in the dermatologic literature discuss facial nerve injury and management. OBJECTIVE: To review facial nerve injury and management, including static and dynamic repair techniques, and to review outcomes in facial nerve reconstruction. METHODS: Two detailed literature reviews were performed using PubMed. First, articles reporting facial nerve injury and/or management in the dermatologic literature were identified. In addition, articles pertaining to outcomes in facial nerve reconstruction with a minimum of 20 patients were included. RESULTS: Fifty-three articles reporting outcomes in facial nerve reconstruction were identified and consist of retrospective reviews and case series. Most patients achieve improvement in facial symmetry and movement with nerve repair. CONCLUSION: Timing of facial nerve repair is an important consideration in management of facial nerve injury, with earlier repairs achieving better outcomes. Facial nerve repair does not result in normal facial movement, and improvements may require a year or more to be realized. Many options exist for facial nerve reconstruction, and patients with long-standing facial nerve injuries may still benefit from treatment.


Subject(s)
Dermatologic Surgical Procedures/adverse effects , Facial Nerve Injuries/etiology , Facial Nerve Injuries/surgery , Facial Muscles/surgery , Facial Muscles/transplantation , Facial Nerve/anatomy & histology , Facial Nerve Injuries/complications , Facial Paralysis/etiology , Facial Paralysis/surgery , Humans , Postoperative Complications/surgery , Time Factors
19.
Dermatol Surg ; 2024 Oct 23.
Article in English | MEDLINE | ID: mdl-39442185
SELECTION OF CITATIONS
SEARCH DETAIL